Search Results - "Balstad, Trude R."

Cancer cachexia: rationale for the MENAC (Multimodal-Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial by Solheim, Tora S, Laird, Barry J A, Balstad, Trude R, Bye, Asta, Stene, Guro, Baracos, Vickie, Strasser, Florian, Griffiths, Gareth, Maddocks, Matthew, Fallon, Marie, Kaasa, Stein, Fearon, Kenneth

“…Cancer cachexia is a multifactorial syndrome characterised by an ongoing loss of skeletal muscle mass that cannot be fully reversed by conventional nutritional…”
Get more information

Exercise and Nutrition Interventions in Patients with Head and Neck Cancer during Curative Treatment: A Systematic Review and Meta-Analysis by Bye, Asta, Sandmael, Jon A, Stene, Guro B, Thorsen, Lene, Balstad, Trude R, Solheim, Tora S, Pripp, Are Hugo, Oldervoll, Line M

“…The aim of this meta-analysis was to examine the effects of nutritional and physical exercise interventions and interventions combining these interventions…”
Get full text

Power Comparisons and Clinical Meaning of Outcome Measures in Assessing Treatment Effect in Cancer Cachexia: Secondary Analysis From a Randomized Pilot Multimodal Intervention Trial by Balstad, Trude R, Brunelli, Cinzia, Pettersen, Caroline H, Schønberg, Svanhild A, Skorpen, Frank, Fallon, Marie, Kaasa, Stein, Bye, Asta, Laird, Barry J A, Stene, Guro B, Solheim, Tora S

“…New clinical trials in cancer cachexia are essential, and outcome measures with high responsiveness to detect meaningful changes are crucial. This secondary…”
Get full text

Physical rehabilitation in patients with head and neck cancer: Impact on health‐related quality of life and suitability of a post‐treatment program by Sandmæl, Jon Arne, Bye, Asta, Solheim, Tora S., Balstad, Trude R., Thorsen, Lene, Skovlund, Eva, Kaasa, Stein, Lund, Jo‐Åsmund, Oldervoll, Line

“…Objective Physical rehabilitation programs hold the potential to mitigate deterioration in health‐related quality of life (HRQoL) in patients with head and…”
Get full text

Activation and Inhibition of Nuclear Factor Kappa B Activity by Cereal Extracts: Role of Dietary Phenolic Acids by Hole, Anastasia S, Grimmer, Stine, Naterstad, Kristine, Jensen, Merete R, Paur, Ingvild, Johansen, Siril G, Balstad, Trude R, Blomhoff, Rune, Sahlstrøm, Stefan

“…The transcription factor nuclear factor kappa B (NF-κB) plays a critical role in stress, immune, and inflammatory responses, and the modulation of its activity…”
Get full text

Effects of current parenteral nutrition treatment on health-related quality of life, physical function, nutritional status, survival and adverse events exclusively in patients with advanced cancer: A systematic literature review by Tobberup, Randi, Thoresen, Lene, Falkmer, Ursula G., Yilmaz, Mette K., Solheim, Tora S., Balstad, Trude R.

“…•Current parenteral nutrition treatment is understudied.•QoL and physical function may be improved by parenteral nutrition during anti-neoplastic treatment in…”
Get full text

Dietary treatment of weight loss in patients with advanced cancer and cachexia: A systematic literature review by Balstad, Trude R, Solheim, Tora S, Strasser, Florian, Kaasa, Stein, Bye, Asta

“…Abstract Purpose A systematical literature review evaluating the effect of dietary counseling in treating weight loss and improving energy intake in patients…”
Get full text

A systematic review examining nutrition support interventions in patients with incurable cancer by Blackwood, Honor A., Hall, Charlie C., Balstad, Trude R., Solheim, Tora S., Fallon, Marie, Haraldsdottir, Erna, Laird, Barry J.

“…Purpose Recent guidelines by the European Society for Clinical Nutrition and Metabolism (ESPEN) have advocated increased attention to nutritional support in…”
Get full text

Validity of dietary intake methods in cancer cachexia by Balstad, Trude R, Bråtveit, Marianne, Solheim, Tora S, Koteng, Lisa Heide, Bye, Asta, Jakobsen, Rasmus Dahl, Schødt-Osmo, Bente, Fjeldstad, Siv Hilde, Erichsen, Marianne, Vagnildhaug, Ola Magne, Paur, Ingvild, Ottestad, Inger O

“…Accurate assessment of dietary intake, especially energy and protein intake, is crucial for optimizing nutritional care and outcomes in patients with cancer…”
Get full text

Endpoints in clinical trials in cancer cachexia: where to start? by Laird, Barry J.A., Balstad, Trude R., Solheim, Tora S.

“…PURPOSE OF REVIEWThe lack of agreement and knowledge of optimal endpoints in cachexia trials have impeded progress in finding interventions counteracting the…”
Get full text

Exploring the barriers to diagnosing malnutrition in patients with cancer: A study on oncologists' perspectives by Koteng, Lisa Heide, Sand, Kari, Paur, Ingvild, Bye, Asta, Ervik, Bente, Solheim, Tora S., Ottestad, Inger, Balstad, Trude R.

“…Patients with cancer are at high risk of malnutrition, yet relevant ICD-10 codes for malnutrition are underutilized in cancer clinics. Understanding…”
Get full text

Development of the EORTC QLQ-CAX24, a questionnaire for cancer patients with cachexia by Wheelwright, S.J, Hopkinson, J.B, Darlington, A.-S, Fitzsimmons, D.F, Fayers, P, Balstad, T.R, Bredart, A, Hammerlid, E, Kaasa, S, Nicolatou-Galitis, O, Pinto, M, Schmidt, H, Solheim, T.S, Strasser, F, Tomaszewska, I.M, Johnson, C.D

“…Abstract Context Cachexia is commonly found in cancer patients and has profound consequences yet there is only one questionnaire that examines the patient’s…”
Get full text

Patient interpretation of the Patient-Generated Subjective Global Assessment (PG-SGA) Short Form by Balstad, Trude R, Bye, Asta, Jenssen, Cathrine Rs, Solheim, Tora S, Thoresen, Lene, Sand, Kari

“…The Patient-Generated Subjective Global Assessment (PG-SGA) is a patient-reported instrument for assessment of nutrition status in patients with cancer…”
Get full text

Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series by Vagnildhaug, Ola Magne, Balstad, Trude R., Ottestad, Inger, Bye, Asta, Greil, Christine, Arends, Jann, Baracos, Vickie, Brown, Leo R., Dajani, Olav F., Dolan, Ross D., Fallon, Marie, Fraser, Eilidh, Grzyb, Aleksandra, Hjermstad, Marianne J., Jakobsen, Gunnhild, Kaasa, Stein, McDonald, James, Philips, Iain, Sayers, Judith, Simpson, Melanie R., Sousa, Mariana S., Skipworth, Richard J.E., Laird, Barry J.A., Solheim, Tora S.

“…There is no consensus on the optimal endpoint(s) in cancer cachexia trials. Endpoint variation is an obstacle when comparing interventions and their clinical…”
Get full text

Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series by Hjermstad, Marianne J., Jakobsen, Gunnhild, Arends, Jann, Balstad, Trude R., Brown, Leo R., Bye, Asta, Coats, Andrew J.S., Dajani, Olav F., Dolan, Ross D., Fallon, Marie T., Greil, Christine, Grzyb, Alexandra, Kaasa, Stein, Koteng, Lisa H., May, Anne M., McDonald, James, Ottestad, Inger, Philips, Iain, Roeland, Eric J., Sayers, Judith, Simpson, Melanie R., Skipworth, Richard J.E., Solheim, Tora S., Sousa, Mariana S., Vagnildhaug, Ola M., Laird, Barry J.A.

“…The use of patient‐reported outcomes (PROMs) of quality of life (QOL) is common in cachexia trials. Patients' self‐report on health, functioning, wellbeing,…”
Get full text

Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series by Brown, Leo R., Sousa, Mariana S., Yule, Michael S., Baracos, Vickie E., McMillan, Donald C., Arends, Jann, Balstad, Trude R., Bye, Asta, Dajani, Olav, Dolan, Ross D., Fallon, Marie T., Greil, Christine, Hjermstad, Marianne J., Jakobsen, Gunnhild, Maddocks, Matthew, McDonald, James, Ottestad, Inger O., Phillips, Iain, Sayers, Judith, Simpson, Melanie R., Vagnildhaug, Ola M., Solheim, Tora S., Laird, Barry J.A., Skipworth, Richard J.E.

“…Significant variation exists in the outcomes used in cancer cachexia trials, including measures of body composition, which are often selected as primary or…”
Get full text

Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series by Yule, Michael S., Thompson, Joshua, Leesahatsawat, Khachonphat, Sousa, Mariana S., Anker, Stefan D., Arends, Jann, Balstad, Trude R., Brown, Leo R., Bye, Asta, Dajani, Olav, Fallon, Marie, Hjermstad, Marianne J., Jakobsen, Gunnhild, McDonald, James, McGovern, Josh, Roeland, Eric J., Sayers, Judith, Skipworth, Richard J.E., Ottestad, Inger O., Philips, Iain, Simpson, Melanie R., Solheim, Tora S., Vagnildhaug, Ola Magne, McMillan, Donald, Laird, Barry J.A., Dolan, Ross D.

“…Regulatory agencies require evidence that endpoints correlate with clinical benefit before they can be used to approve drugs. Biomarkers are often considered…”
Get full text

Corrigendum to “Dietary treatment of weight loss in patients with advanced cancer and cachexia: A systematic literature review” [Crit. Rev. Oncol./Hematol. 91 (2014) 210–221] by Balstad, Trude R, Solheim, Tora S, Strasser, Florian, Kaasa, Stein, Bye, Asta

Get full text

Parenteral Nutrition in Advanced Cancer: The Healthcare Providers’ Perspective by Balstad, Trude R., Løhre, Erik T., Thoresen, Lene, Thronæs, Morten, Skjelvan, Laila S., Helgås, Ragnhild G., Solheim, Tora S., Sand, Kari

“…Introduction The evidence base for parenteral nutrition (PN) in advanced cancer patients is limited. We studied healthcare providers’ (HCPs’) experiences with…”
Get full text

Plant extracts of spices and coffee synergistically dampen nuclear factor– κ B in U937 cells by Kolberg, Marit, Paur, Ingvild, Balstad, Trude R, Pedersen, Sigrid, Jacobs, David R, Blomhoff, Rune

“…Abstract A large array of bioactive plant compounds (phytochemicals) has been identified and synergy among these compounds might contribute to the beneficial…”
Get full text